The 2024 PM360 Pharma Choice Awards – Unbranded Silver Winner

RevHealth for Merus

Face the Fusions Disease Education Campaign

The rapid expansion of precision medicine has led to a growing “alphabet soup” of genomic alterations leaving knowledge gaps with oncologists. Face the Fusions campaign brings attention to a single important truth: “What you don’t know can hurt them,” creating awareness of the importance of seeing pathogenic gene fusions.

Congratulations to THE ENTIRE REVHEALTH TEAM

Ads

You May Also Like

How Technology & Collaboration Will Move the Needle on Diversity in Clinical Research

Good science dictates we make investments in diversity and inclusion to create representative populations ...

2017 Pharma Choice Bronze DTC/DTP

Dudnyk Shire Firazyr “Mantra” Patient and physician insights uncovered an opportunity to encourage patients ...

Odysseys with Peter Sonnenreich

PM360 asked Peter Sonnenreich about the place many people in pharma can’t stop returning ...